Canadian cannabis producer Organigram reported a loss of 248.6 million Canadian dollars ($185 million) in the 2023 fiscal year, postponed its free cash flow guidance and appointed a permanent chief financial officer.
Cannabis producer Organigram report…
organigram
Canadians love weed, so why can’t brands stay in business?
Nearly four years after legalization, Canadian cannabis companies are still struggling. What exactly is the problem?
The post Canadians love weed, so why can’t brands stay in business? appeared first on Leafly.
Canadians love weed, so why can’t brands stay in business?
Nearly four years after legalization, Canadian cannabis companies are still struggling. What exactly is the problem?
The post Canadians love weed, so why can’t brands stay in business? appeared first on Leafly.
Why cannabis producer Organigram struck a CA$220 million deal with a tobacco giant: Q&A with CEO Greg Engel
While rival Canadian cannabis producers plowed massive amounts of capital into cultivation infrastructure, losing billions of dollars in the process, New Brunswick-based Organigram forged a different path. Organigram – which trades on the Nasdaq …
British American Tobacco buying stake in cannabis producer Organigram
A subsidiary of British cigarette maker British American Tobacco (BAT) and Atlantic Canada-based cannabis producer Organigram have signed a 220 million Canadian dollar ($175 million) strategic collaboration with a focus on research and product developm…
Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?
Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical cannabis companies, analysts and industry sources say. But rather than all cannabis pro…
Will GW’s multibillion-dollar sale ‘open floodgates’ to pharma-cannabis deal-making?
Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical cannabis companies, analysts and industry sources say. But rather than all cannabis pro…
Organigram revenue stalls on inconsistent inventory, unfulfilled demand
New Brunswick-based cannabis producer Organigram continues to struggle, reporting lower sales and a bigger loss for its first quarter ended Nov. 30, 2020. Net revenue for the three-month period fell to 19.3 million Canadian dollars ($15 million), lower…
Canadian cannabis firm Organigram reports CA$136M loss for year
New Brunswick-based cannabis producer Organigram reported a net loss of 136 million Canadian dollars ($105 million) for its fiscal year 2020, a substantial increase from the company’s previous annual loss of CA$9.5 million. Organigram lost CA$39 …